Applications from Agilent Technologies | LabRulez ICPMS

Demonstrating Inertness for the Analysis of Nucleotides on the Agilent 1290 Infinity II Bio LC

Technical notes

| 2022 | Agilent Technologies

HPLC

Instrumentation

HPLC

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Demonstrating Inertness for the Analysis of Nucleotides on the Agilent 1290 Infinity II Bio LC

Technical notes

| 2022 | Agilent Technologies

HPLC

Instrumentation

HPLC

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

Applications

| 2020 | Agilent Technologies

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Lipidomics

A New Lipidomics Software Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

Posters

| 2019 | Agilent Technologies

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Clinical Research, Lipidomics

The Agilent InfinityLab 2D-LC ProtA‑SEC Kit and Service

Brochures and specifications

| 2021 | Agilent Technologies

Consumables, LC columns, 2D-LC, GPC/SEC

Instrumentation

Consumables, LC columns, 2D-LC, GPC/SEC

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Instrument Detection Limit at Ultrashort Dwell Times Demonstrated on the Agilent 6495C Triple Quadrupole LC/MS

Technical notes

| 2020 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Metabolomics: An Improved Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

Posters

| 2019 | Agilent Technologies (Metabolomics)

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Clinical Research, Lipidomics

Robustness and Metal Release Testing of the New Agilent 1260 Infinity Bio-inert LC with Agilent 7700 ICP-MS

Posters

| N/A | Agilent Technologies

HPLC, ICP/MS, Speciation analysis

Instrumentation

HPLC, ICP/MS, Speciation analysis

Manufacturer

Agilent Technologies

Industries

High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using pH-gradient Cation Exchange Chromatography

Applications

| 2017 | Agilent Technologies

Consumables, HPLC, LC columns

Instrumentation

Consumables, HPLC, LC columns

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Performance Comparison of Agilent 1290 Infinity Binary and Quaternary Systems as an MS Front-End

Applications

| 2014 | Agilent Technologies

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Food & Agriculture

Applications from Agilent Technologies | LabRulez ICPMS

Demonstrating Inertness for the Analysis of Nucleotides on the Agilent 1290 Infinity II Bio LC

Demonstrating Inertness for the Analysis of Nucleotides on the Agilent 1290 Infinity II Bio LC

Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

A New Lipidomics Software Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

The Agilent InfinityLab 2D-LC ProtA‑SEC Kit and Service

Instrument Detection Limit at Ultrashort Dwell Times Demonstrated on the Agilent 6495C Triple Quadrupole LC/MS

Metabolomics: An Improved Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

Robustness and Metal Release Testing of the New Agilent 1260 Infinity Bio-inert LC with Agilent 7700 ICP-MS

High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using pH-gradient Cation Exchange Chromatography

Performance Comparison of Agilent 1290 Infinity Binary and Quaternary Systems as an MS Front-End

Related content

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

Cryo-EM structures show how Trypanosomes escape the human innate immune response

An innovative approach to planar chiral substances